CIK 0001813814
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,023,010
- in 6 filings, $3.0M under 10b5-1 plans
Net −$3,023,010. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Barrow Robert −$1.9M Chief Executive Officer sold 2% of stake
- Sullivan Mark −$514K Chief Legal Officer sold 3% of stake
- Karlin Daniel −$397K Chief Medical Officer sold 1% of stake
- Roberts Brandi −$123K Chief Financial Officer sold <1% of stake
- Wiley Matthew T. −$113K Chief Commercial Officer sold <1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | CRYSTAL ROGER Director | Grant or award | +4,666 | 24,289 | ||
| 2026-06-11 | CRYSTAL ROGER Director | Grant or award · Stock Option (Right to Buy) | +19,188 | 19,188 | ||
| 2025-06-12 | CRYSTAL ROGER Director | Grant or award · Stock Option (Right to Buy) | +75,187 | 75,187 | ||
| 2024-06-10 | CRYSTAL ROGER Director | Grant or award · Stock Option (Right to Buy) | +16,506 | 16,506 | ||
| 2023-06-21 | CRYSTAL ROGER Director | Grant or award | +13,671 | 19,623 | ||
| 2023-06-21 | CRYSTAL ROGER Director | Grant or award · Stock Option (Right to Buy) | +19,203 | 27,267 | ||
| 2022-08-11 | CRYSTAL ROGER Director | Grant or award | +89,286 | 89,286 | ||
| 2022-08-11 | CRYSTAL ROGER Director | Grant or award · Stock Option (Right to Buy) | +120,968 | 120,968 | ||
| 2022-08-11 | CRYSTAL ROGER Director | Grant or award · Director's Deferred Share Units | +503,773 | 503,773 |
Page 1 of 1 · 9 trades